Protalix BioTherapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2010 | 103.3% | -451.2% | -436.6% |
| FY2011 | 17.2% | -435.6% | -435.6% |
| FY2012 | 75.4% | -34.9% | -33.3% |
| FY2014 | 82.1% | -810.6% | -849.9% |
| FY2015 | 83.3% | -542.4% | 1,329.9% |
| FY2016 | 8.7% | -360.5% | -319.2% |
| FY2017 | 19.0% | -163.8% | -395.9% |
| FY2018 | 72.8% | -56.4% | -77.3% |
| FY2019 | 80.1% | -19.6% | -33.4% |